Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Leukemia 40Myelodysplastic Syndromes 38Leukemia, Myeloid, Acute 34Lymphoma 31Leukemia, Lymphocytic, Chronic, B-Cell 31Lymphoma, Non-Hodgkin 28Hodgkin Disease 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Multiple Myeloma 25Myeloproliferative Disorders 21Lymphoma, Large B-Cell, Diffuse 21Lymphoma, Follicular 21Lymphoma, B-Cell, Marginal Zone 21Lymphoma, Mantle-Cell 20Lymphoma, Large-Cell, Immunoblastic 17Burkitt Lymphoma 17Primary Myelofibrosis 16Neoplasms, Plasma Cell 16Leukemia, Myeloid, Accelerated Phase 16Congenital Abnormalities 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Lymphoma, T-Cell, Cutaneous 14Leukemia, Myelomonocytic, Chronic 14Leukemia, Myeloid, Chronic-Phase 14Graft vs Host Disease 14Blast Crisis 13Hematologic Neoplasms 12Waldenstrom Macroglobulinemia 11Sezary Syndrome 11Lymphoma, Extranodal NK-T-Cell 11

Interventions

fludarabine phosphate 3Whole-Body Irradiation 3Cyclosporins 2Cyclosporine 2Cyclophosphamide 2Antilymphocyte Serum 2Alemtuzumab 2thymoglobulin 1plerixafor 1fosphenytoin 1fludarabine 1Thiotepa 1Therapeutics 1Tacrolimus 1Phlebotomy 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Busulfan 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Immunologic Deficiency Syndromes × Antilymphocyte Serum × Clear all
NCT02274662 2025-01-16

Expanded Access Protocol Thymus Transplantation

Sumitomo Pharma Switzerland GmbH

Phase 4 Completed
11 enrolled 10 charts

Thymic aplasia, Immunologic Deficiency Syndromes

NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡